Literature DB >> 12467527

Expression of a splice variant of the platelet-activating factor receptor transcript 2 in various human cancer cell lines.

Ibtissam Youlyouz1, Emmanuelle Magnoux, Laurence Guglielmi, Yves Denizot.   

Abstract

Platelet-activating factor receptor (PAF-R) transcripts were analysed by reverse transcriptase-polymerase chain reaction in five human cancer cell lines derived from the breast (BT20, SKBR3 and T47D cells), the pancreas (Miapaca cells) and the bladder (5,637 cells) in order to confirm the existence of a splice variant of the PAF-R transcript 2. After cloning and sequencing, we confirmed its existence in all cell lines. It consisted of the PAF-R transcript 2 lengthening with 82 nucleotides from the 3' end of exon 1 of the PAF-R gene. The role of this elongated form of the tissue-type PAF-R transcript in cell physiology remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467527      PMCID: PMC1781672          DOI: 10.1080/09629350210000015755

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  5 in total

1.  Inhibition by platelet-activating factor of Src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3'-kinase is a critical mediator of tumor invasion.

Authors:  L Kotelevets; V Noë; E Bruyneel; E Myssiakine; E Chastre; M Mareel; C Gespach
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

2.  Metabolism and effect of platelet-activating factor on the growth of human myeloma cell lines.

Authors:  V Desplat; C Dulery; J L Faucher; V Praloran; Y Denizot
Journal:  Cancer Lett       Date:  2000-02-28       Impact factor: 8.679

3.  Expression of platelet-activating factor receptor transcript-1 but not transcript-2 by human bone marrow cells.

Authors:  V Desplat; A Besse; J L Faucher; V Praloran; Y Denizot
Journal:  Stem Cells       Date:  1999       Impact factor: 6.277

Review 4.  Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice.

Authors:  S Ishii; T Shimizu
Journal:  Prog Lipid Res       Date:  2000-01       Impact factor: 16.195

5.  Two different promoters direct expression of two distinct forms of mRNAs of human platelet-activating factor receptor.

Authors:  H Mutoh; H Bito; M Minami; M Nakamura; Z Honda; T Izumi; R Nakata; Y Kurachi; A Terano; T Shimizu
Journal:  FEBS Lett       Date:  1993-05-10       Impact factor: 4.124

  5 in total
  1 in total

1.  Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers.

Authors:  B Xu; L Gao; L Wang; G Tang; M He; Y Yu; X Ni; Y Sun
Journal:  Br J Cancer       Date:  2013-08-15       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.